The much-anticipated guideline is now available for RQA members.
More information
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationEMA has published four documents relating to veterinary medicine for public consultation.
The MHRA’s industry newsletter highlights key regulatory news and updates as the year begins.
Updates on the ACT EU initiative, CTIS and the clinical trials landscape in the EU
The EMA are pleased to inform you that a webinar on the use of platform technologies in the non-clinical and clinical domains will be held on 2 March 2026 from 09:25 to 12:15 CET.
The FDA’s Clinical Decision Support Software guidance explains the agency’s regulatory approach for CDS tools used in healthcare.
Quarterly news, activities and interviews from EMA Veterinary Medicines Division
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has begun its 2026 term as Chair of the Access Consortium, strengthening global regulatory collaboration to improve patient access to new medicines.
Title: WHO statement on notification of withdrawal of the United States
The European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) published key outcomes from its January 2026 meeting, including opinions on new veterinary medicines and updated guidance initiatives.
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) met in mid-January 2026 to review emerging safety data and ongoing pharmacovigilance activities.